_id
691488aeccc777a4e85d97dc
Ticker
ORGO
Name
Organogenesis Holdings Inc
Exchange
NASDAQ
Address
85 Dan Road, Canton, MA, United States, 02021
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://organogenesis.com
Description
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFU); Dermagraft, a dermal substitute grown from human dermal fibroblasts to treat DFUs; NuShield, a dehydrated placental allograft and surgical barrier to provide a protective barrier and ECM scaffold to support native healing; PuraPly Antimicrobial (AM) and PuraPly SX, which are antimicrobial barriers for the management of open wounds in surgical settings; and CYGNUS Dual, a dual-layered amniotic tissue graft used to treat chronic and acute wounds. It also provides PuraPly MZ, a micronized version of PuraPly for the management of open wounds in surgical settings; FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; TransCyte, a bioengineered tissue scaffold that promotes burn healing; and PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications. In addition, the company develops ReNu, a cryopreserved suspension, which is in Phase 3 trial, for the management of symptoms associated with knee osteoarthritis; and placental products. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices through direct sales representatives and independent agencies. Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts.
Last Close
4.73
Volume
1323359
Current Price
4.7618
Change
0.6723044397462918
Last Updated
2025-12-02T13:09:23.374Z
Image
data:image/webp;base64,UklGRmgBAABXRUJQVlA4IFwBAADQCACdASpAAEAAPrVQoEynJKMiLBK6aOAWiUAZL4EJl+zZbJDPB5fMARWzg08umO20k50/b4AOSP9zIb9HI7VDb2ON+XGocW0XgJqNoQrwAP71WL/byM6KRn9fPslbiIfIgcGk8OUtMAdUjnKNQXiFcOwZjg8PL/DUax7DQcQYmgOkBmZ7ColMUEKrcdHDT81fiiS4FCJiZH5YZ5IXMxFmGhOgJI+MSD+az4DtBuRsfEzI+bl7f9JdYmDQ7IRnGBtYNnN7TSm00KntzrPl/jkf4Vk3qzcej2u/g11kqG7Io85n2hm0uR/nvpP+1iS1/DhMPcU5zUJ/UaV9/pLhlgeXqjbVV6XysBSbABTdYmZTZD8zbGyUEc2FKNx8gTeZndrZLioRzVbdd/PDeJ9ZWzTOZoW/PYAJ/1T/IRIhGW1ZzDXPE0QAQv21DWbluPdHSaFX0hnfU4ydte0AAAA=
Ipo Date
2017-01-05T00:00:00.000Z
Market Cap
644713664
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.957
Sentiment Sources
1
Rating
4.5
Target Price
8.5
Strong Buy
3
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
150864000
Cost Of Revenue
36251000
Gross Profit
114613000
Operating Expenses
93886000
Operating Income
20727000
Interest Expense
415000
Pretax Income
21973999
Net Income
21567000
Eps
0.16482358156438268
Dividends Per Share
5622000
Shares Outstanding
126912142
Income Tax Expense
406999
EBITDA
27259999
Operating Margin
13.738864142538976
Total Other Income Expense Net
1246999
Cash
64372000
Short Term Investments
-
Receivables
168783000
Inventories
39583000
Total Current Assets
299749000
Property Plant Equipment
111362000
Total Assets
509827000
Payables
40219000
Short Term Debt
9790000
Long Term Debt
-
Total Liabilities
123848000
Equity
385979000
Depreciation
6987000
Change In Working Capital
-29880000
Cash From Operations
3079000
Capital Expenditures
2235000
Cash From Investing
-2235000
Cash From Financing
-10207000
Net Change In Cash
-9363000
PE
-
PB
1.6142762802924513
ROE
5.587609688610002
ROA
4.230258499451775
FCF
844000
Fcf Percent
0.005594442676848022
Piotroski FScore
3
Health Score
57
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
7
Garp Investing Score
6
Growth Investing Score
4.5
Momentum Investing Score
3
Net Net Investing Score
4
Quality Investing Score
7.5
Value Investing Score
8.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
150864000
Quarters > 0 > income Statement > cost Of Revenue
36251000
Quarters > 0 > income Statement > gross Profit
114613000
Quarters > 0 > income Statement > operating Expenses
93886000
Quarters > 0 > income Statement > operating Income
20727000
Quarters > 0 > income Statement > interest Expense
415000
Quarters > 0 > income Statement > pretax Income
21973999
Quarters > 0 > income Statement > net Income
21567000
Quarters > 0 > income Statement > eps
0.16482358156438268
Quarters > 0 > income Statement > dividends Per Share
5622000
Quarters > 0 > income Statement > shares Outstanding
130848995
Quarters > 0 > income Statement > income Tax Expense
406999
Quarters > 0 > income Statement > EBITDA
27259999
Quarters > 0 > income Statement > operating Margin
13.738864142538976
Quarters > 0 > income Statement > total Other Income Expense Net
1246999
Quarters > 0 > balance Sheet > cash
64372000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
168783000
Quarters > 0 > balance Sheet > inventories
39583000
Quarters > 0 > balance Sheet > total Current Assets
299749000
Quarters > 0 > balance Sheet > property Plant Equipment
111362000
Quarters > 0 > balance Sheet > total Assets
509827000
Quarters > 0 > balance Sheet > payables
40219000
Quarters > 0 > balance Sheet > short Term Debt
9790000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
123848000
Quarters > 0 > balance Sheet > equity
385979000
Quarters > 0 > cash Flow > net Income
21567000
Quarters > 0 > cash Flow > depreciation
6987000
Quarters > 0 > cash Flow > change In Working Capital
-29880000
Quarters > 0 > cash Flow > cash From Operations
3079000
Quarters > 0 > cash Flow > capital Expenditures
2235000
Quarters > 0 > cash Flow > cash From Investing
-2235000
Quarters > 0 > cash Flow > cash From Financing
-10207000
Quarters > 0 > cash Flow > net Change In Cash
-9363000
Quarters > 0 > ratios > PE
0.16482358156438268
Quarters > 0 > ratios > PB
1.6142762802924513
Quarters > 0 > ratios > ROE
5.587609688610002
Quarters > 0 > ratios > ROA
4.230258499451775
Quarters > 0 > ratios > FCF
844000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.005594442676848022
Quarters > 0 > health Score
57
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
100779000
Quarters > 1 > income Statement > cost Of Revenue
27630000
Quarters > 1 > income Statement > gross Profit
73149000
Quarters > 1 > income Statement > operating Expenses
85725000
Quarters > 1 > income Statement > operating Income
-12576000
Quarters > 1 > income Statement > interest Expense
669000
Quarters > 1 > income Statement > pretax Income
-11834000
Quarters > 1 > income Statement > net Income
-9392000
Quarters > 1 > income Statement > eps
-0.07403814112048086
Quarters > 1 > income Statement > dividends Per Share
2810000
Quarters > 1 > income Statement > shares Outstanding
126853536
Quarters > 1 > income Statement > income Tax Expense
-2442000
Quarters > 1 > income Statement > EBITDA
-6255000
Quarters > 1 > income Statement > operating Margin
-12.478790224153842
Quarters > 1 > income Statement > total Other Income Expense Net
742000
Quarters > 1 > balance Sheet > cash
73076000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
120382000
Quarters > 1 > balance Sheet > inventories
33042000
Quarters > 1 > balance Sheet > total Current Assets
260223000
Quarters > 1 > balance Sheet > property Plant Equipment
110864000
Quarters > 1 > balance Sheet > total Assets
461128000
Quarters > 1 > balance Sheet > payables
29723000
Quarters > 1 > balance Sheet > short Term Debt
9768000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
99909000
Quarters > 1 > balance Sheet > equity
361219000
Quarters > 1 > cash Flow > net Income
-9392000
Quarters > 1 > cash Flow > depreciation
4575000
Quarters > 1 > cash Flow > change In Working Capital
-38120000
Quarters > 1 > cash Flow > cash From Operations
-32873000
Quarters > 1 > cash Flow > capital Expenditures
3638000
Quarters > 1 > cash Flow > cash From Investing
-3638000
Quarters > 1 > cash Flow > cash From Financing
-288000
Quarters > 1 > cash Flow > net Change In Cash
-36799000
Quarters > 1 > ratios > PE
-0.07403814112048086
Quarters > 1 > ratios > PB
1.6722574607780873
Quarters > 1 > ratios > ROE
-2.600084713151855
Quarters > 1 > ratios > ROA
-2.0367446782672056
Quarters > 1 > ratios > FCF
-36511000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.36228777820776153
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
86693000
Quarters > 2 > income Statement > cost Of Revenue
23723000
Quarters > 2 > income Statement > gross Profit
62970000
Quarters > 2 > income Statement > operating Expenses
89716000
Quarters > 2 > income Statement > operating Income
-26746000
Quarters > 2 > income Statement > interest Expense
961000
Quarters > 2 > income Statement > pretax Income
-25783000
Quarters > 2 > income Statement > net Income
-18843000
Quarters > 2 > income Statement > eps
-0.14919754713309902
Quarters > 2 > income Statement > dividends Per Share
1798000
Quarters > 2 > income Statement > shares Outstanding
126295642
Quarters > 2 > income Statement > income Tax Expense
-6940000
Quarters > 2 > income Statement > EBITDA
-15893000
Quarters > 2 > income Statement > operating Margin
-30.8513951530112
Quarters > 2 > income Statement > total Other Income Expense Net
963000
Quarters > 2 > balance Sheet > cash
109965000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
103320000
Quarters > 2 > balance Sheet > inventories
29338000
Quarters > 2 > balance Sheet > total Current Assets
268160000
Quarters > 2 > balance Sheet > property Plant Equipment
112274000
Quarters > 2 > balance Sheet > total Assets
467394000
Quarters > 2 > balance Sheet > payables
24660000
Quarters > 2 > balance Sheet > short Term Debt
9258000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
99325000
Quarters > 2 > balance Sheet > equity
368069000
Quarters > 2 > cash Flow > net Income
-18843000
Quarters > 2 > cash Flow > depreciation
6283000
Quarters > 2 > cash Flow > change In Working Capital
-20713000
Quarters > 2 > cash Flow > cash From Operations
-19935000
Quarters > 2 > cash Flow > capital Expenditures
3626000
Quarters > 2 > cash Flow > cash From Investing
-3626000
Quarters > 2 > cash Flow > cash From Financing
-2056000
Quarters > 2 > cash Flow > net Change In Cash
-25617000
Quarters > 2 > ratios > PE
-0.14919754713309902
Quarters > 2 > ratios > PB
1.633918064481388
Quarters > 2 > ratios > ROE
-5.119420543430715
Quarters > 2 > ratios > ROA
-4.03150232994005
Quarters > 2 > ratios > FCF
-23561000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.27177511448444513
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
126656000
Quarters > 3 > income Statement > cost Of Revenue
31051000
Quarters > 3 > income Statement > gross Profit
95605000
Quarters > 3 > income Statement > operating Expenses
85386000
Quarters > 3 > income Statement > operating Income
10219000
Quarters > 3 > income Statement > interest Expense
61000
Quarters > 3 > income Statement > pretax Income
10253000
Quarters > 3 > income Statement > net Income
7673000
Quarters > 3 > income Statement > eps
0.05805737291182051
Quarters > 3 > income Statement > dividends Per Share
1798000
Quarters > 3 > income Statement > shares Outstanding
132162370
Quarters > 3 > income Statement > income Tax Expense
2580000
Quarters > 3 > income Statement > EBITDA
14641000
Quarters > 3 > income Statement > operating Margin
8.068311015664477
Quarters > 3 > income Statement > total Other Income Expense Net
34000
Quarters > 3 > balance Sheet > cash
135571000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
109861000
Quarters > 3 > balance Sheet > inventories
26219000
Quarters > 3 > balance Sheet > total Current Assets
285941000
Quarters > 3 > balance Sheet > property Plant Equipment
126238000
Quarters > 3 > balance Sheet > total Assets
497886000
Quarters > 3 > balance Sheet > payables
28911000
Quarters > 3 > balance Sheet > short Term Debt
9113000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
112570000
Quarters > 3 > balance Sheet > equity
385316000
Quarters > 3 > cash Flow > net Income
7673000
Quarters > 3 > cash Flow > depreciation
6420000
Quarters > 3 > cash Flow > change In Working Capital
-6779000
Quarters > 3 > cash Flow > cash From Operations
10937000
Quarters > 3 > cash Flow > capital Expenditures
3361000
Quarters > 3 > cash Flow > cash From Investing
-3361000
Quarters > 3 > cash Flow > cash From Financing
33649000
Quarters > 3 > cash Flow > net Change In Cash
41225000
Quarters > 3 > ratios > PE
0.05805737291182051
Quarters > 3 > ratios > PB
1.633284819384609
Quarters > 3 > ratios > ROE
1.9913525521909292
Quarters > 3 > ratios > ROA
1.541115837762058
Quarters > 3 > ratios > FCF
7576000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.0598155634158666
Quarters > 3 > health Score
58
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
482043000
Annuals > 0 > income Statement > cost Of Revenue
115741000
Annuals > 0 > income Statement > gross Profit
366302000
Annuals > 0 > income Statement > operating Expenses
367585000
Annuals > 0 > income Statement > operating Income
-1283000
Annuals > 0 > income Statement > interest Expense
1544000
Annuals > 0 > income Statement > pretax Income
-2807000
Annuals > 0 > income Statement > net Income
861000
Annuals > 0 > income Statement > eps
0.006538912170167131
Annuals > 0 > income Statement > dividends Per Share
1798000
Annuals > 0 > income Statement > shares Outstanding
131673278
Annuals > 0 > income Statement > income Tax Expense
-3668000
Annuals > 0 > income Statement > EBITDA
15763000
Annuals > 0 > income Statement > operating Margin
-0.2661588281543348
Annuals > 0 > income Statement > total Other Income Expense Net
-1524000
Annuals > 0 > balance Sheet > cash
135571000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
109861000
Annuals > 0 > balance Sheet > inventories
26219000
Annuals > 0 > balance Sheet > total Current Assets
285941000
Annuals > 0 > balance Sheet > property Plant Equipment
126238000
Annuals > 0 > balance Sheet > total Assets
497886000
Annuals > 0 > balance Sheet > payables
28911000
Annuals > 0 > balance Sheet > short Term Debt
9113000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
112570000
Annuals > 0 > balance Sheet > equity
385316000
Annuals > 0 > cash Flow > net Income
861000
Annuals > 0 > cash Flow > depreciation
17026000
Annuals > 0 > cash Flow > change In Working Capital
-48889000
Annuals > 0 > cash Flow > cash From Operations
14208000
Annuals > 0 > cash Flow > capital Expenditures
10032000
Annuals > 0 > cash Flow > cash From Investing
-10032000
Annuals > 0 > cash Flow > cash From Financing
27637000
Annuals > 0 > cash Flow > net Change In Cash
31813000
Annuals > 0 > ratios > PE
0.006538912170167131
Annuals > 0 > ratios > PB
1.7359783975749774
Annuals > 0 > ratios > ROE
0.22345295809154045
Annuals > 0 > ratios > ROA
0.1729311529145226
Annuals > 0 > ratios > FCF
4176000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.008663127563308667
Annuals > 0 > health Score
50
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
433140000
Annuals > 1 > income Statement > cost Of Revenue
106481000
Annuals > 1 > income Statement > gross Profit
326659000
Annuals > 1 > income Statement > operating Expenses
314134000
Annuals > 1 > income Statement > operating Income
12525000
Annuals > 1 > income Statement > interest Expense
2190000
Annuals > 1 > income Statement > pretax Income
10392000
Annuals > 1 > income Statement > net Income
4945000
Annuals > 1 > income Statement > eps
0.03725138925647485
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
132746727
Annuals > 1 > income Statement > income Tax Expense
5447000
Annuals > 1 > income Statement > EBITDA
36031000
Annuals > 1 > income Statement > operating Margin
2.8916747471949025
Annuals > 1 > income Statement > total Other Income Expense Net
-2133000
Annuals > 1 > balance Sheet > cash
104338000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
81999000
Annuals > 1 > balance Sheet > inventories
28253000
Annuals > 1 > balance Sheet > total Current Assets
225044000
Annuals > 1 > balance Sheet > property Plant Equipment
156346000
Annuals > 1 > balance Sheet > total Assets
460025000
Annuals > 1 > balance Sheet > payables
30724000
Annuals > 1 > balance Sheet > short Term Debt
19711000
Annuals > 1 > balance Sheet > long Term Debt
60745000
Annuals > 1 > balance Sheet > total Liabilities
181362000
Annuals > 1 > balance Sheet > equity
278663000
Annuals > 1 > cash Flow > net Income
4945000
Annuals > 1 > cash Flow > depreciation
23449000
Annuals > 1 > cash Flow > change In Working Capital
-18073000
Annuals > 1 > cash Flow > cash From Operations
30917000
Annuals > 1 > cash Flow > capital Expenditures
24364000
Annuals > 1 > cash Flow > cash From Investing
-24364000
Annuals > 1 > cash Flow > cash From Financing
-5505000
Annuals > 1 > cash Flow > net Change In Cash
1048000
Annuals > 1 > ratios > PE
0.03725138925647485
Annuals > 1 > ratios > PB
2.4199602141654974
Annuals > 1 > ratios > ROE
1.7745448803752204
Annuals > 1 > ratios > ROA
1.0749415792619965
Annuals > 1 > ratios > FCF
6553000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.015129057579535485
Annuals > 1 > health Score
48
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
450893000
Annuals > 2 > income Statement > cost Of Revenue
105019000
Annuals > 2 > income Statement > gross Profit
345874000
Annuals > 2 > income Statement > operating Expenses
323570000
Annuals > 2 > income Statement > operating Income
22304000
Annuals > 2 > income Statement > interest Expense
2009000
Annuals > 2 > income Statement > pretax Income
20282000
Annuals > 2 > income Statement > net Income
15532000
Annuals > 2 > income Statement > eps
0.11732610808360266
Annuals > 2 > income Statement > dividends Per Share
648000
Annuals > 2 > income Statement > shares Outstanding
132383152
Annuals > 2 > income Statement > income Tax Expense
4750000
Annuals > 2 > income Statement > EBITDA
40322000
Annuals > 2 > income Statement > operating Margin
4.946628135721779
Annuals > 2 > income Statement > total Other Income Expense Net
-2022000
Annuals > 2 > balance Sheet > cash
102478000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
89450000
Annuals > 2 > balance Sheet > inventories
24783000
Annuals > 2 > balance Sheet > total Current Assets
222609000
Annuals > 2 > balance Sheet > property Plant Equipment
145655000
Annuals > 2 > balance Sheet > total Assets
449359000
Annuals > 2 > balance Sheet > payables
32330000
Annuals > 2 > balance Sheet > short Term Debt
16246000
Annuals > 2 > balance Sheet > long Term Debt
66231000
Annuals > 2 > balance Sheet > total Liabilities
183690000
Annuals > 2 > balance Sheet > equity
265669000
Annuals > 2 > cash Flow > net Income
15532000
Annuals > 2 > cash Flow > depreciation
10728000
Annuals > 2 > cash Flow > change In Working Capital
-34082000
Annuals > 2 > cash Flow > cash From Operations
24859000
Annuals > 2 > cash Flow > capital Expenditures
33898000
Annuals > 2 > cash Flow > cash From Investing
-33898000
Annuals > 2 > cash Flow > cash From Financing
-2199000
Annuals > 2 > cash Flow > net Change In Cash
-11238000
Annuals > 2 > ratios > PE
0.11732610808360266
Annuals > 2 > ratios > PB
2.5313695318610754
Annuals > 2 > ratios > ROE
5.846372742021087
Annuals > 2 > ratios > ROA
3.456479118032575
Annuals > 2 > ratios > FCF
-9039000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
-0.020046884737620677
Annuals > 2 > health Score
55
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
467359000
Annuals > 3 > income Statement > cost Of Revenue
114199000
Annuals > 3 > income Statement > gross Profit
353160000
Annuals > 3 > income Statement > operating Expenses
280942000
Annuals > 3 > income Statement > operating Income
72218000
Annuals > 3 > income Statement > interest Expense
7236000
Annuals > 3 > income Statement > pretax Income
63086000
Annuals > 3 > income Statement > net Income
94202000
Annuals > 3 > income Statement > eps
0.7047742534044176
Annuals > 3 > income Statement > dividends Per Share
1461000
Annuals > 3 > income Statement > shares Outstanding
133662658
Annuals > 3 > income Statement > income Tax Expense
-31116000
Annuals > 3 > income Statement > EBITDA
86998000
Annuals > 3 > income Statement > operating Margin
15.452361032953254
Annuals > 3 > income Statement > total Other Income Expense Net
-9132000
Annuals > 3 > balance Sheet > cash
113929000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
82460000
Annuals > 3 > balance Sheet > inventories
25022000
Annuals > 3 > balance Sheet > total Current Assets
226979000
Annuals > 3 > balance Sheet > property Plant Equipment
128304000
Annuals > 3 > balance Sheet > total Assets
443259000
Annuals > 3 > balance Sheet > payables
29339000
Annuals > 3 > balance Sheet > short Term Debt
14641000
Annuals > 3 > balance Sheet > long Term Debt
70769000
Annuals > 3 > balance Sheet > total Liabilities
201924000
Annuals > 3 > balance Sheet > equity
241335000
Annuals > 3 > cash Flow > net Income
94902000
Annuals > 3 > cash Flow > depreciation
16676000
Annuals > 3 > cash Flow > change In Working Capital
-39288000
Annuals > 3 > cash Flow > cash From Operations
61978000
Annuals > 3 > cash Flow > capital Expenditures
31220000
Annuals > 3 > cash Flow > cash From Investing
-31220000
Annuals > 3 > cash Flow > cash From Financing
-1036000
Annuals > 3 > cash Flow > net Change In Cash
29722000
Annuals > 3 > ratios > PE
0.7047742534044176
Annuals > 3 > ratios > PB
2.8135425969710153
Annuals > 3 > ratios > ROE
39.03370833074357
Annuals > 3 > ratios > ROA
21.252134756429086
Annuals > 3 > ratios > FCF
30758000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.06581236265911217
Annuals > 3 > health Score
76
Valuation > metrics > PE
0.16482358156438268
Valuation > metrics > PB
1.6142762802924513
Valuation > final Score
100
Valuation > verdict
49.2% Undervalued
Profitability > metrics > ROE
5.587609688610002
Profitability > metrics > ROA
7.195019833260495
Profitability > metrics > Net Margin
0.142956570155902
Profitability > final Score
54
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3208671974382026
Risk > metrics > Interest Coverage
49.94457831325301
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.993901097802396
Liquidity > metrics > Quick Ratio
5.2023835709572275
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
100
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
21
Prev Risks > 0
-15
Prev Risks > 1
-51
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:52:32.066Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0.16
Earnings History > 0 > eps Difference
-0.16
Earnings History > 0 > surprise Percent
-100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.1775
Earnings History > 1 > eps Estimate
0.0629
Earnings History > 1 > eps Difference
0.1146
Earnings History > 1 > surprise Percent
182.194
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.1
Earnings History > 2 > eps Estimate
-0.05
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-100
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.04
Earnings History > 3 > eps Difference
-0.13
Earnings History > 3 > surprise Percent
-325
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.0662
Earnings History > 4 > eps Estimate
0.02
Earnings History > 4 > eps Difference
0.0462
Earnings History > 4 > surprise Percent
231
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0966
Earnings History > 5 > eps Estimate
-0.01
Earnings History > 5 > eps Difference
0.1066
Earnings History > 5 > surprise Percent
1066
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.04
Earnings History > 6 > eps Estimate
-0.01
Earnings History > 6 > eps Difference
0.05
Earnings History > 6 > surprise Percent
500
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.02
Earnings History > 7 > eps Estimate
-0.03
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
33.3333
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0043
Earnings History > 8 > eps Estimate
0.01
Earnings History > 8 > eps Difference
-0.0143
Earnings History > 8 > surprise Percent
-143
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.02
Earnings History > 9 > eps Estimate
0.01
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
100
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.04
Earnings History > 10 > eps Estimate
0.03
Earnings History > 10 > eps Difference
0.01
Earnings History > 10 > surprise Percent
33.3333
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-10
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.02
Earnings History > 11 > eps Estimate
-0.02
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-01
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.06
Earnings History > 12 > eps Estimate
0.05
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
20
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.0369
Earnings History > 13 > eps Estimate
0.06
Earnings History > 13 > eps Difference
-0.0231
Earnings History > 13 > surprise Percent
-38.5
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.07
Earnings History > 14 > eps Estimate
0.08
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-12.5
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-10
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0091
Earnings History > 15 > eps Estimate
0.05
Earnings History > 15 > eps Difference
-0.0409
Earnings History > 15 > surprise Percent
-81.8
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-01
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.39
Earnings History > 16 > eps Estimate
0.08
Earnings History > 16 > eps Difference
0.31
Earnings History > 16 > surprise Percent
387.5
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.1
Earnings History > 17 > eps Estimate
0.06
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
66.6667
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.15
Earnings History > 18 > eps Estimate
0.07
Earnings History > 18 > eps Difference
0.08
Earnings History > 18 > surprise Percent
114.2857
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.07
Earnings History > 19 > eps Estimate
-0.02
Earnings History > 19 > eps Difference
0.09
Earnings History > 19 > surprise Percent
450
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-16
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.15
Earnings History > 20 > eps Estimate
0.14
Earnings History > 20 > eps Difference
0.01
Earnings History > 20 > surprise Percent
7.1429
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-09
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.19
Earnings History > 21 > eps Estimate
-0.08
Earnings History > 21 > eps Difference
0.27
Earnings History > 21 > surprise Percent
337.5
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-10
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.05
Earnings History > 22 > eps Estimate
-0.23
Earnings History > 22 > eps Difference
0.18
Earnings History > 22 > surprise Percent
78.2609
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-11
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.17
Earnings History > 23 > eps Estimate
-0.13
Earnings History > 23 > eps Difference
-0.04
Earnings History > 23 > surprise Percent
-30.7692
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-09
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.04
Earnings History > 24 > eps Estimate
-0.09
Earnings History > 24 > eps Difference
0.05
Earnings History > 24 > surprise Percent
55.5556
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-12
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.12
Earnings History > 25 > eps Estimate
-0.13
Earnings History > 25 > eps Difference
0.01
Earnings History > 25 > surprise Percent
7.6923
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-09
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.11
Earnings History > 26 > eps Estimate
-0.12
Earnings History > 26 > eps Difference
0.01
Earnings History > 26 > surprise Percent
8.3333
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-10
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.15
Earnings History > 27 > eps Estimate
-0.11
Earnings History > 27 > eps Difference
-0.04
Earnings History > 27 > surprise Percent
-36.3636
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-18
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.12
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-14
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
0.5
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-13
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
0.04
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-14
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.01
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-02-28
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.13
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-15
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.3
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-14
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.04
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-15
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
0.02
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-01
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.0225
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFU); Dermagraft, a dermal substitute grown from human dermal fibroblasts to treat DFUs; NuShield, a dehydrated placental allograft and surgical barrier to provide a protective barrier and ECM scaffold to support native healing; PuraPly Antimicrobial (AM) and PuraPly SX, which are antimicrobial barriers for the management of open wounds in surgical settings; and CYGNUS Dual, a dual-layered amniotic tissue graft used to treat chronic and acute wounds. It also provides PuraPly MZ, a micronized version of PuraPly for the management of open wounds in surgical settings; FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; TransCyte, a bioengineered tissue scaffold that promotes burn healing; and PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications. In addition, the company develops ReNu, a cryopreserved suspension, which is in Phase 3 trial, for the management of symptoms associated with knee osteoarthritis; and placental products. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices through direct sales representatives and independent agencies. Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOrganogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO) Seeking Alpha
Read more →Investors in cash trouble should check out Organogenesis Holdings Inc (ORGO) Setenews
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$8.5
Analyst Picks
Strong Buy
3
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 58.37% of the total shares of Organogenesis Holdings Inc
1.
Soleus Capital Management, L.P.(9.7301%)
since
2025/06/30
2.
Morgan Stanley - Brokerage Accounts(9.5035%)
since
2025/06/30
3.
First Light Asset Management, LLC(5.3423%)
since
2025/06/30
4.
Vanguard Group Inc(4.0966%)
since
2025/06/30
5.
BlackRock Inc(3.7317%)
since
2025/06/30
6.
Deutsche Bank AG(2.584%)
since
2025/06/30
7.
Xtrackers S&P 500 Swap ETF 1C(2.5603%)
since
2025/07/31
8.
Dimensional Fund Advisors, Inc.(2.4473%)
since
2025/06/30
9.
Assenagon Asset Management SA(2.2528%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(1.5235%)
since
2025/07/31
11.
iShares Russell 2000 ETF(1.3445%)
since
2025/08/31
12.
Geode Capital Management, LLC(1.3195%)
since
2025/06/30
13.
State Street Corp(1.1892%)
since
2025/06/30
14.
Charles Schwab Investment Management Inc(0.7557%)
since
2025/06/30
15.
Renaissance Technologies Corp(0.6337%)
since
2025/06/30
16.
Northern Trust Corp(0.6213%)
since
2025/06/30
17.
Vanguard Institutional Extnd Mkt Idx Tr(0.6121%)
since
2025/07/31
18.
AQR Capital Management LLC(0.5653%)
since
2025/06/30
19.
Fidelity Small Cap Index(0.5396%)
since
2025/06/30
20.
Vanguard Explorer Inv(0.5266%)
since
2025/06/30
21.
iShares Russell 2000 Growth ETF(0.4843%)
since
2025/08/31
22.
D. E. Shaw & Co LP(0.4833%)
since
2025/06/30
23.
Connor Clark & Lunn Inv Mgmt Ltd(0.4676%)
since
2025/06/30
24.
DFA US Targeted Value I(0.4418%)
since
2025/07/31
25.
State Of Wisconsin Investment Board(0.4156%)
since
2025/06/30
26.
UBS Group AG(0.3936%)
since
2025/06/30
27.
Bank of America Corp(0.379%)
since
2025/06/30
28.
Dimensional US Targeted Value ETF(0.3661%)
since
2025/08/29
29.
Wellington Management Company LLP(0.3306%)
since
2025/06/30
30.
Schwab Small-Cap Equity(0.3016%)
since
2025/06/30
31.
Fidelity Extended Market Index(0.3%)
since
2025/07/31
32.
DFA US Small Cap I(0.2845%)
since
2025/07/31
33.
Vanguard Strategic Equity Inv(0.2633%)
since
2025/06/30
34.
Schwab US Small-Cap ETFâ„¢(0.2592%)
since
2025/08/30
35.
Dimensional US Small Cap ETF(0.2581%)
since
2025/08/29
36.
Vanguard Russell 2000 ETF(0.2558%)
since
2025/07/31
37.
DFA US Micro Cap I(0.2357%)
since
2025/07/31
38.
State St Russell Sm Cap® Indx SL Cl I(0.2105%)
since
2025/08/31
39.
Lazard US Sm Cap Eq WW Dist EUR(0.2088%)
since
2025/05/31
40.
NT Quality Small Cap Value(0.1515%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.16
Date
2025-09-30
EPS Actual
0.1775
EPS Estimate
0.0629
EPS Difference
0.1146
Surprise Percent
182.194%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.